QbD-driven solid dispersion development for enhanced solubility and dissolution of the BCS Class II drug voriconazole as a model drug
Voriconazole (VC), a second-generation triazole antifungal, suffers from low aqueous solubility (∼0.5 mg mL −1 ), which restricts its oral bioavailability.
Authors
- Bhaskar Daravath (ORCID: https://orcid.org/0000-0001-8181-4134)
- UDAY KIRAN KUMMARI
- C RAVITEJA
Institutions
- GITAM University (IN)
Publication Details
- Journal
- RSC Pharmaceutics
- Published
- 2025-12-03
- DOI
- https://doi.org/10.1039/d5pm00241a
- Primary Topic
- Antifungal resistance and susceptibility
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Gandhi Institute of Technology and Management